Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis’s Gilenya Reviewed After 11 Deaths
Novartis’s Gilenya Reviewed After 11 Deaths
Novartis’s Gilenya Reviewed After 11 Deaths
Submitted by
admin
on January 20, 2012 - 10:06am
Source:
Bloomberg
News Tags:
Novartis
Gilenya
MS
multiple sclerosis
EMA
Headline:
Novartis’s Gilenya Reviewed After 11 Deaths
Do Not Allow Advertisers to Use My Personal information
